Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In the ELIXA CVOT, lixisenatide was found to be non-inferior to standard of care plus placebo in terms of risk of the composite endpoint (cardiovascular death, myocardial infarction, stroke, or hospitalization for unstable angina)13.4% in the lixisenatide group and 13.2% in the placebo group (hazard ratio, 1.02
Copper peptides fit all three
Whether youre visiting family over the holidays, taking a spring break vacation, or heading out of state for a business trip
Tirzepatide: Published Research Summary A trial-by-trial reading of the tirzepatide literature, organized as three research waves: bench pharmacology and cryo-EM structure, the SURPASS diabetes program, and the SURMOUNT weight-management program
Ozempic is a GLP-1 receptor agonist that works on appetite and how food moves through the digestive tract
Effect of ischaemia-reperfusion on glutathione peroxidase, glutathione reductase and [PMID: 2318422] Laboratory literature summary: Effect of ischaemia-reperfusion on glutathione peroxidase, glutathione reductase and glutathione transferase activities in research
US$ 20.18
US$ 23.70
US$ 23.75
US$ 24.98
US$ 27.78
US$ 27.74
US$ 24.52
